• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
Citation: LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
shu

Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives

More Information
    Graphical Abstract
    • Abstract
  • A series of oxazole［5, 4-d］pyrimidine derivatives were designed and synthesized to discover novel compounds with antitumor activity. Compounds 8a - 8m were synthesized using acetamidine hydrochloride as the start material. The structures of synthesized compounds were confirmed by IR, 1H NMR, EI-MS and elemental analysis. The antiangiogenesis activities of the synthesized compounds were determined by MTT in human umbilical vein endothelial cell(HUVEC). The in vitro antitumor activities of the synthesized compounds were determined by MTT assay in A549, HepG2 and U251. Compounds 8c , 8d , 8g , 8i and 8l were found to inhibit the proliferation of all the tested cell lines. Compound 8l exhibited noteworthy activities in A549, HepG2 and U251 cell lines with IC50value lower than the positive reference sunitinib, suggesting that compound 8l might be the promising antitumor agent for further investigation.
    • FullText(HTML)
    • References (12)
  • [1]
    Zhao PL,You WW,Duan AN.Research advances in antitumor activities of pyrimidine derivatives[J].Acta Pharm Sin(药学学报),2012,47(5):580-587.
    [2]
    Burchat AF,Calderwood DJ,Friedman MM,et al.Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck-a selectivity insight[J].Bioorg Med Chem Lett,2002,12(12):1687-1690.
    [3]
    Kim S, Schiff BA, Younes MN, et al. Treatment with NVP AEE788-a dual inhibitor of EFGR and VEGFR tyrosine kinase-inhibits anaplastic thyroid carcinoma growth[J].Clin Cancer Res,2003,9(16):6100S-6101S.
    [4]
    Dai Y, Guo Y, Frey RR, et al. Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors[J].J Med Chem,2005,48(19):6066-6083.
    [5]
    Miyazaki Y,Matsunaga S,Tang J,et al.Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors[J].Bioorg Med Chem Lett,2005,15(9):2203-2207.
    [6]
    Miller DJ,Ravikumar K,Shen H,et al.Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibiton[J].J Med Chem,2002,45(1):90-98.
    [7]
    Yildiz-Oren I,Yalcin I,Aki-Sener E,et al.Synthesis and structure-activity relationships of new antimicrobial active multi substituted benzazolederivatives[J].Eur J Med Chem,2004,39(3):291-298.
    [8]
    Bauser M,Delapierre G,Hauswlad M,et al.Discovery and optimization of 2-aryl oxzaolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis[J].Bioorg Med Chem Lett,2004,14(8):1997-2000.
    [9]
    Xu D,Sun LP,You QD.Facile synthesis of 2,5,7-trisubstituted oxazolo[5,4-d]pyrimidines via copper-catalyzed intramolecular C-O bond formation[J].Tetrahedron,2012,68(22):4248-4251.
    [10]
    Polverino A,Coxon A,Starnes C,et al.AMG 706,an oral,multikinase inhibitor that selectively targets vascular endothelial growth factor,platelet-derived growth factor,and kit receptors,potently inhibits angiogenesis and induces regression in tumor xenografts[J].Cancer Res,2006,66(17):8715-8721.
    [11]
    Mao ZW, Wan CP, Jiang Y, et al. Synthesis and anti-tumor activity in vitro of N-heterocycle substitutes benzofuranderivatives[J].J China Pharm Univ(中国药科大学学报),2015,46(1):58-61.
    [12]
    Liang XW,Xu FM,Li XG,et al.VEGF signal system:the application of antiangiogenesis[J].Curr Med Chem,2014,21(7):894-910.
    • Related Articles

  • Related Articles

    [1]SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405
    [2]QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305
    [3]MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
    [4]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [5]CHENG Keguang, CHU Xiangwu, LIU Guanyan, SU Chunhua, DENG Shengping, PAN Hongmei. Synthesis and antitumor activities of 3-substituted estradiol-pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 26-32. DOI: 10.11665/j.issn.1000-5048.20140104
    [6]LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605
    [7]LIANG Xiao-qing, SHI Chen-yang, WANG Ke, HE Xin, LIU Si-guo, HUANG Xiao-feng, LIU Yu. Anti-angiogenesis and anti-tumor activity of the fully human anti-VEGF165 monoclonal antibody obtained from the five-feature transgenic mice[J]. Journal of China Pharmaceutical University, 2012, 43(6): 560-566.
    [8]LIU Kun, DONG Jin, SUN Jing, CHU Zhao-xing, HE Shu-ying, XU Yun-gen. Synthesis and anti-angiogenesis evaluation of mutual prodrugs of lenalidomide and glucosamines[J]. Journal of China Pharmaceutical University, 2012, 43(6): 486-491.
    [9]HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119.
    [10]ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498.

Catalog

    Get Citation
    PDF
    XML
    Article views (954) PDF downloads (1629) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：414881

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return